Chutes & Ladders—Biopharma veteran takes her CEO Cue Read more →
Odyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline Read more →
Banyan BioInnovations puts down roots with $100M, Icon partnership Read more →
« All Events
February 5, 2025 @ 8:30 am
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.